Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mutational signatures of DNA damage and repair processes Mutagen Exposure Pilot

ABSTRACT: Pilot study for mutagen exposure work to be carried out as part of mutational signatures project.

PROVIDER: EGAS00001000778 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Mutational signatures are jointly shaped by DNA damage and repair.

Project description: Not available

| S-EPMC7195458 | biostudies-literature

Signatures of mutational processes in human cancer.

Project description: Not available

| S-EPMC3776390 | biostudies-literature

Mutational signatures of aflatoxin

Project description:Aflatoxin B1 (AFB1) is a mutagen and IARC (International Agency for Research on Cancer) Group 1 carcinogen that causes hepatocellular carcinoma (HCC). Here we present the first whole genome data on the mutational signatures of AFB1 exposure from a total of > 40,000 mutations in four experimental systems: two different human cell lines, and in liver tumors in wild-type mice and in mice that carried a hepatitis B surface antigen transgene – this to model the multiplicative effects of aflatoxin exposure and hepatitis B in causing HCC. AFB1 mutational signatures from all four experimental systems were remarkably similar. We integrated the experimental mutational signatures with data from newly-sequenced HCCs from Qidong County, China, a region of well-studied aflatoxin exposure. This indicated that COSMIC mutational signature 24, previously hypothesized to stem from aflatoxin exposure, indeed likely represents AFB1 exposure, possibly combined with other exposures. Among published somatic mutation data, we found evidence of AFB1 exposure in 0.7% of HCCs treated in North America, 1% of HCCs from Japan, but 16% of HCCs from Hong Kong. Thus, aflatoxin exposure apparently remains a substantial public health issue in some areas. This aspect of our study exemplifies the promise of future widespread resequencing of tumor genomes in providing new insights into the contribution of mutagenic exposures to cancer incidence.

| EGAS00001002490 | EGA

EGAS00001000778-sc-20160302 - samples

Project description:Pilot study for mutagen exposure work to be carried out as part of mutational signatures project.

| EGAD00001001934 | EGA

Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.

Project description: Not available

| S-EPMC8497615 | biostudies-literature

Copy number signatures and mutational processes in ovarian carcinoma.

Project description: Not available

| S-EPMC6130818 | biostudies-literature

Deciphering signatures of mutational processes operative in human cancer.

Project description: Not available

| S-EPMC3588146 | biostudies-literature

A compendium of mutational signatures due to environmental exposures

Project description:Analysis of mutational signatures caused by exposure to known mutagens in human induced pluripotent stem (iPS) cells. A reference human iPS cell-line will be exposed to 100 chemicals known or proposed to be mutagenic. Following exposure to mutagen, cells will undergo a period of recovery before sub clones are generated and sequenced. The progenitor “parental” IPS cell-line will be used to generate reference sequence data, in order to determine the mutational signatures acquired as a result of exposure to different mutagens.

| EGAS00001002060 | EGA

Clone decomposition based on mutation signatures provides novel insights into mutational processes.

Project description: Not available

| S-EPMC8559167 | biostudies-literature

Chlamydia trachomatis pilot

Project description:Chlamydia trachomatis pilot

| PRJEB2214 | ENA